SC 13G

Company

SELLAS Life Sciences Group, Inc.

Filed

July 15, 2016

Accession Number

0001104659-16-132751

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →